We are committed to finding a cure for WM.

Did you know?

 

Welcome to the Waldenstrom’s Macroglobulinemia Foundation of Canada (WMFC)

If you have been diagnosed with Waldenstrom’s Macroglobulinemia (WM) or care for someone who has, welcome to the WMFC family of WM patients, caregivers, friends and relatives. We are a community providing support, research and information on WM.

Sign up for our newsletter below to receive updated information.

 

Information for the newly diagnosed

Member Post – Cognitive Behavioural Therapy (CBT) as an aid for tackling anxiety.

Cognitive Behavioural Therapy (CBT) as an aid for tackling anxiety. – Michael Collins Cognitive Behavioural Therapy gives you quick, practical and goal-driven skills to help you tackle the acute anxietyRead More

Video: IMBRUVICA (ibrutinib) in Combination With Rituximab for Waldenstrom’s Macroglobulinemia

The following link is to the Cancer Therapy Advisor website featuring the following video IMBRUVICA (ibrutinib) in Combination With Rituximab for Waldenstrom’s Macroglobulinemia Meletios Dimopoulos, MD, discusses his findings atRead More

Article: Reducing Dose Intensity May Be Associated with Shortened PFS in Waldenstrom Macroglobulinemia

https://www.cancertherapyadvisor.com/hematologic-cancers/waldenstrom-macroglobulinemia-lower-dosage-intensity-shorter-survival/article/767850/ Reducing Dose Intensity May Be Associated with Shortened PFS in Waldenstrom Macroglobulinemia James Nam, PharmD May 22, 2018 Share this content: Decreasing the dose intensity (DI) of ibrutinib mayRead More

Article: High Rates of Response, Survival With Ibrutinib Plus Rituximab in Waldenström Macroglobulinemia

High Rates of Response, Survival With Ibrutinib Plus Rituximab in Waldenström Macroglobulinemia Saturday, June 2, 2018 Treatment with a combination of ibrutinib and rituximab improved progression-free survival (PFS) over rituximabRead More

Subscribe to our newsletter